Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 20 studies | 30% ± 13% | |
astrocyte | 16 studies | 38% ± 17% | |
macrophage | 12 studies | 34% ± 14% | |
oligodendrocyte | 12 studies | 30% ± 11% | |
microglial cell | 11 studies | 45% ± 12% | |
GABAergic neuron | 10 studies | 42% ± 24% | |
glutamatergic neuron | 10 studies | 48% ± 24% | |
oligodendrocyte precursor cell | 10 studies | 37% ± 14% | |
adipocyte | 9 studies | 39% ± 10% | |
fibroblast | 9 studies | 29% ± 10% | |
myeloid cell | 8 studies | 28% ± 11% | |
B cell | 7 studies | 20% ± 6% | |
epithelial cell | 7 studies | 36% ± 16% | |
dendritic cell | 7 studies | 29% ± 10% | |
smooth muscle cell | 7 studies | 23% ± 8% | |
natural killer cell | 6 studies | 21% ± 5% | |
neuron | 6 studies | 43% ± 16% | |
interneuron | 6 studies | 47% ± 22% | |
retina horizontal cell | 6 studies | 23% ± 5% | |
pericyte | 6 studies | 26% ± 9% | |
ciliated cell | 6 studies | 25% ± 6% | |
T cell | 6 studies | 21% ± 4% | |
type II pneumocyte | 6 studies | 29% ± 9% | |
basal cell | 6 studies | 30% ± 17% | |
CD16-positive, CD56-dim natural killer cell, human | 5 studies | 18% ± 3% | |
retinal ganglion cell | 5 studies | 40% ± 6% | |
amacrine cell | 5 studies | 27% ± 5% | |
endothelial cell of lymphatic vessel | 5 studies | 31% ± 9% | |
monocyte | 5 studies | 30% ± 8% | |
club cell | 5 studies | 27% ± 7% | |
type I pneumocyte | 5 studies | 28% ± 8% | |
CD4-positive, alpha-beta T cell | 4 studies | 19% ± 3% | |
effector memory CD8-positive, alpha-beta T cell | 4 studies | 20% ± 3% | |
non-classical monocyte | 4 studies | 21% ± 5% | |
granule cell | 4 studies | 30% ± 8% | |
CD8-positive, alpha-beta T cell | 4 studies | 19% ± 2% | |
cardiac muscle cell | 4 studies | 31% ± 5% | |
lymphocyte | 4 studies | 35% ± 10% | |
Mueller cell | 4 studies | 24% ± 5% | |
retinal rod cell | 4 studies | 22% ± 4% | |
hepatocyte | 4 studies | 61% ± 13% | |
GABAergic interneuron | 3 studies | 35% ± 1% | |
glial cell | 3 studies | 21% ± 6% | |
plasma cell | 3 studies | 32% ± 4% | |
retinal pigment epithelial cell | 3 studies | 33% ± 20% | |
mast cell | 3 studies | 27% ± 13% | |
mononuclear phagocyte | 3 studies | 23% ± 9% | |
vein endothelial cell | 3 studies | 30% ± 18% | |
GABAergic amacrine cell | 3 studies | 27% ± 8% | |
OFF-bipolar cell | 3 studies | 27% ± 7% | |
ON-bipolar cell | 3 studies | 24% ± 3% | |
glycinergic amacrine cell | 3 studies | 24% ± 3% | |
rod bipolar cell | 3 studies | 21% ± 5% | |
ependymal cell | 3 studies | 40% ± 15% | |
alveolar macrophage | 3 studies | 36% ± 11% | |
respiratory goblet cell | 3 studies | 35% ± 9% | |
goblet cell | 3 studies | 39% ± 26% | |
transit amplifying cell | 3 studies | 35% ± 24% | |
brush cell | 3 studies | 21% ± 4% | |
plasmacytoid dendritic cell | 3 studies | 21% ± 4% | |
mucus secreting cell | 3 studies | 31% ± 7% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 17 studies | 37% ± 19% | |
lung | 7 studies | 23% ± 7% | |
eye | 6 studies | 26% ± 15% | |
heart | 4 studies | 25% ± 7% | |
peripheral blood | 3 studies | 19% ± 0% | |
liver | 3 studies | 41% ± 19% | |
intestine | 3 studies | 18% ± 0% | |
adipose | 3 studies | 35% ± 11% | |
kidney | 3 studies | 27% ± 5% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 5024.79 | 1445 / 1445 | 100% | 37.20 | 183 / 183 |
liver | 100% | 6701.26 | 226 / 226 | 100% | 71.00 | 406 / 406 |
pancreas | 100% | 3073.34 | 328 / 328 | 100% | 42.93 | 178 / 178 |
prostate | 100% | 6634.84 | 245 / 245 | 100% | 71.87 | 502 / 502 |
thymus | 100% | 7272.77 | 653 / 653 | 100% | 49.23 | 605 / 605 |
uterus | 100% | 5604.58 | 170 / 170 | 100% | 39.31 | 459 / 459 |
brain | 100% | 5630.92 | 2637 / 2642 | 100% | 58.70 | 705 / 705 |
skin | 100% | 4440.77 | 1809 / 1809 | 100% | 49.48 | 471 / 472 |
lung | 100% | 5235.52 | 578 / 578 | 100% | 37.95 | 1151 / 1155 |
intestine | 100% | 5384.72 | 966 / 966 | 100% | 36.08 | 525 / 527 |
kidney | 100% | 5186.53 | 89 / 89 | 100% | 34.17 | 897 / 901 |
breast | 100% | 4734.16 | 459 / 459 | 100% | 40.54 | 1113 / 1118 |
stomach | 100% | 4601.90 | 359 / 359 | 99% | 34.21 | 284 / 286 |
bladder | 100% | 4699.76 | 21 / 21 | 99% | 37.29 | 500 / 504 |
adrenal gland | 100% | 6121.63 | 258 / 258 | 97% | 43.90 | 223 / 230 |
ovary | 100% | 4862.33 | 180 / 180 | 97% | 23.70 | 416 / 430 |
adipose | 100% | 4115.07 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 45.91 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 56.40 | 29 / 29 |
muscle | 100% | 6164.13 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 6455.63 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 43.85 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 23.92 | 1 / 1 |
blood vessel | 100% | 4022.53 | 1333 / 1335 | 0% | 0 | 0 / 0 |
heart | 99% | 3584.04 | 851 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 96% | 3350.02 | 895 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0043666 | Biological process | regulation of phosphoprotein phosphatase activity |
GO_0005829 | Cellular component | cytosol |
GO_0036464 | Cellular component | cytoplasmic ribonucleoprotein granule |
GO_0005634 | Cellular component | nucleus |
GO_0019888 | Molecular function | protein phosphatase regulator activity |
GO_0005515 | Molecular function | protein binding |
GO_0019903 | Molecular function | protein phosphatase binding |
Gene name | PPP6R2 |
Protein name | Protein phosphatase 6 regulatory subunit 2 Serine/threonine-protein phosphatase 6 regulatory subunit 2 (SAPS domain family member 2) |
Synonyms | PP6R2 KIAA0685 SAPS2 |
Description | FUNCTION: Regulatory subunit of protein phosphatase 6 (PP6). May function as a scaffolding PP6 subunit. Involved in the PP6-mediated dephosphorylation of NFKBIE opposing its degradation in response to TNF-alpha. . |
Accessions | ENST00000395744.7 [O75170-4] A0A0A0MSJ8 ENST00000216061.9 [O75170-1] ENST00000612753.5 [O75170-5] ENST00000427222.2 T1ECW5 ENST00000395741.7 [O75170-3] ENST00000401672.7 O75170 ENST00000359139.7 [O75170-2] |